Boris Rychlý

1.2k total citations
54 papers, 747 citations indexed

About

Boris Rychlý is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Boris Rychlý has authored 54 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Molecular Biology and 13 papers in Genetics. Recurrent topics in Boris Rychlý's work include Glioma Diagnosis and Treatment (10 papers), Pituitary Gland Disorders and Treatments (5 papers) and Cancer and Skin Lesions (5 papers). Boris Rychlý is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Pituitary Gland Disorders and Treatments (5 papers) and Cancer and Skin Lesions (5 papers). Boris Rychlý collaborates with scholars based in Slovakia, Czechia and United States. Boris Rychlý's co-authors include Č Altaner, Boris Mravec, Veronika Altanerová, Katarína Ondičová, Marina Cihova, Michal Babič, Tibor Hlavatý, M Huorka, T. Köller and Marián Švajdler and has published in prestigious journals such as International Journal of Molecular Sciences, International Journal of Cancer and Applied Surface Science.

In The Last Decade

Boris Rychlý

51 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boris Rychlý Slovakia 15 250 225 204 175 142 54 747
Theodora Hadjistilianou Italy 20 318 1.3× 317 1.4× 211 1.0× 161 0.9× 95 0.7× 90 1.2k
Óscar Quintana-Bustamante Spain 15 472 1.9× 116 0.5× 226 1.1× 206 1.2× 141 1.0× 32 999
Aeree Kim South Korea 19 323 1.3× 350 1.6× 265 1.3× 170 1.0× 67 0.5× 69 1.1k
Pietro Leocata Italy 18 224 0.9× 184 0.8× 232 1.1× 75 0.4× 57 0.4× 61 824
Frédéric Lambert Belgium 11 197 0.8× 196 0.9× 97 0.5× 91 0.5× 49 0.3× 23 772
Keigo Hanada Japan 8 294 1.2× 121 0.5× 154 0.8× 203 1.2× 107 0.8× 13 819
Mariona Suñol Spain 19 544 2.2× 148 0.7× 205 1.0× 274 1.6× 76 0.5× 64 1.2k
Philip A. Bondzie United States 10 403 1.6× 114 0.5× 169 0.8× 161 0.9× 55 0.4× 13 863
Daniel Dan Liu United States 12 461 1.8× 187 0.8× 182 0.9× 303 1.7× 41 0.3× 20 979
Joan García‐López Spain 14 259 1.0× 210 0.9× 167 0.8× 337 1.9× 99 0.7× 20 1.1k

Countries citing papers authored by Boris Rychlý

Since Specialization
Citations

This map shows the geographic impact of Boris Rychlý's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Rychlý with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Rychlý more than expected).

Fields of papers citing papers by Boris Rychlý

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Rychlý. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Rychlý. The network helps show where Boris Rychlý may publish in the future.

Co-authorship network of co-authors of Boris Rychlý

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Rychlý. A scholar is included among the top collaborators of Boris Rychlý based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Rychlý. Boris Rychlý is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Švajdler, Marián, David Netuka, Boris Rychlý, et al.. (2025). Glycoprotein nonmetastatic melanoma protein b immunohistochemistry can be a useful ancillary tool to diagnose subependymal giant cell astrocytoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.
3.
Ďurmanová, Vladimı́ra, Jan Kozák, Boris Rychlý, et al.. (2025). Association of Klotho Gene Polymorphism and Serum Level of α Klotho Protein with Different Tumor Grades, Overall Survival and Cytokine Profile in Glioma Patients. International Journal of Molecular Sciences. 26(1). 330–330. 1 indexed citations
5.
Pivovarčíková, Kristýna, Petr Martínek, Kiril Trpkov, et al.. (2019). Fumarate hydratase deficient renal cell carcinoma and fumarate hydratase deficient-like renal cell carcinoma: Morphologic comparative study of 23 genetically tested cases.. PubMed. 55(4). 244–249. 3 indexed citations
8.
Janega, Pavol, et al.. (2016). Dominant neurologic symptomatology in intravascular large B-cell lymphoma. Bratislavské lekárske listy/Bratislava medical journal. 117(6). 308–311. 3 indexed citations
9.
Michal, Michael, Dmitry V. Kazakov, Ladislav Hadravský, et al.. (2016). Multivacuolated mucin-filled cells: a unique cell characteristic of plexiform neurofibroma. A report of 11 cases. Human Pathology. 60. 167–173. 4 indexed citations
10.
Kopáni, Martin, et al.. (2016). Cristobalite and Hematite Particles in Human Brain. Biological Trace Element Research. 174(1). 52–57. 4 indexed citations
11.
Michalová, Květoslava, Dmitry V. Kazakov, Michael Michal, et al.. (2016). Differentiated squamous intraepithelial lesion (dSIL)-like changes in the epidermis overlying anogenital melanocytic nevi: A diagnostic pitfall. Annals of Diagnostic Pathology. 26. 43–46. 1 indexed citations
13.
Žilinská, Zuzana, J. Breza, Daniel Kuba, et al.. (2015). Expression of HLA-G transcripts in graft biopsy samples of renal transplant recipients. Transplant Immunology. 33(3). 159–165. 12 indexed citations
14.
Šteňo, Andrej, et al.. (2014). Nonfunctioning pituitary adenomas: association of Ki-67 and HMGA-1 labeling indices with residual tumor growth. Acta Neurochirurgica. 156(3). 451–461. 24 indexed citations
15.
Rychlý, Boris, et al.. (2013). The immune status in situ of recurrent tonsillitis and idiopathic tonsillar hypertrophy. Bratislavské lekárske listy/Bratislava medical journal. 114(3). 140–144. 10 indexed citations
16.
Altanerová, Veronika, Marina Cihova, Michal Babič, et al.. (2011). Human adipose tissue‐derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma. International Journal of Cancer. 130(10). 2455–2463. 83 indexed citations
17.
Skálová, Alena, Radek Šíma, Roderick H.W. Simpson, et al.. (2011). Cribriform Adenocarcinoma of Minor Salivary Gland Origin Principally Affecting the Tongue. The American Journal of Surgical Pathology. 35(8). 1168–1176. 78 indexed citations
18.
Rychlý, Boris, et al.. (2010). Primary Adenomyoepithelioma of the Sellar Region. The American Journal of Surgical Pathology. 34(10). 1550–1554. 7 indexed citations
19.
Rychlý, Boris, et al.. (2009). Post-therapeutical changes in the brain: novel trends in imaging and their infuence on external beam radiotherapy. Neoplasma. 56(2). 156–162. 3 indexed citations
20.
Štěňo, Juraj, et al.. (2009). MR imaging of late radiation therapy- and chemotherapy-induced injury: a pictorial essay. European Radiology. 19(11). 2716–2727. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026